Skip to main content
OpenTrials

Clinical trial condition

Meningitis, Meningococcal

Explore clinical trials studying Meningitis, Meningococcal. Study availability and eligibility vary by location and protocol.

109 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Meningitis, Meningococcal trial results

Completed

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe

NCT03547271

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations
  • Investigational Site Number : 2031006 Chlumec nad Cidlinou, Czechia
  • Investigational Site Number : 2031013 Domažlice, Czechia
  • Investigational Site Number : 2031010 Jindřichův Hradec, Czechia
  • Investigational Site Number : 2031012 Jindřichův Hradec, Czechia
View all 33 locations
View Trial Details
Completed

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

NCT03537508

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Birmingham Pediatric Associates Site Number : 8400026 Birmingham, Alabama, United States
  • Southeastern Pediatric Associates Site Number : 8400003 Dothan, Alabama, United States
  • MedPharmics, LLC - Phoenix Site Number : 8400083 Phoenix, Arizona, United States
  • Northwest Arkansas Pediatric Clinic Site Number : 8400011 Fayetteville, Arkansas, United States
View all 70 locations
View Trial Details
Completed

Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine

NCT04707391

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Banning, California, United States
  • GSK Investigational Site Chula Vista, California, United States
  • GSK Investigational Site West Covina, California, United States
View all 69 locations
View Trial Details
Completed

A Sourcing Study to Collect Human Blood Samples From Healthy Adults

NCT03493919

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations
  • GSK Investigational Site Sydney, New South Wales, Australia
  • GSK Investigational Site Adelaide, South Australia, Australia
  • GSK Investigational Site Geelong, Victoria, Australia
  • GSK Investigational Site Melbourne, Victoria, Australia
View Trial Details
Completed

Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine in Children

NCT03476135

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations
  • Sanofi Pasteur Investigational Site 2460005 Espoo, Finland
  • Sanofi Pasteur Investigational Site 2460006 Helsinki, Finland
  • Sanofi Pasteur Investigational Site 2460002 Helsinki, Finland
  • Sanofi Pasteur Investigational Site 2460007 Jarvenpaa, Finland
View Trial Details
Completed

Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine

NCT02842853

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Birmingham, Alabama, United States
  • Dothan, Alabama, United States
  • Mobile, Alabama, United States
  • Glendale, Arizona, United States
View all 89 locations
View Trial Details

Related conditions